BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9480	Companies
185563	Keywords
117965	Articles
99397	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 05/13/2025 at 09:10, 6 months 23 days ago

BioNxt Expands Capabilities with New Munich Lab Integration

Drug Delivery Pharmaceutical Innovation BioNxt Solutions BNT23001 Munich Laboratory
BRIEF

published on 05/13/2025 at 09:10, 6 months 23 days ago

BioNxt étend ses capacités avec l'intégration d'un nouveau laboratoire à Munich

Innovation Pharmaceutique Solutions BioNxt Administration De Médicaments BNT23001 Laboratoire De Munich
PRESS RELEASE

published on 05/13/2025 at 09:05, 6 months 23 days ago

BioNxt Reports Expanded Research, Development and Commercialization Capability with Centralized Munich Laboratory
BioNxt Solutions Inc. partners with Gen-Plus GmbH for advanced drug delivery system development at Munich lab. Collaboration enhances innovation potential in European biotech hub

Research And Development BioNxt Solutions Inc. Gen-Plus GmbH Drug Delivery Systems Munich Lab
BRIEF

published on 05/05/2025 at 09:10, 7 months ago

BioNxt Solutions Secures Patent Acceptance from Eurasian Patent Organization

Innovation Autoimmune Diseases Drug Delivery BioNxt Solutions Eurasian Patent
BRIEF

published on 05/05/2025 at 09:10, 7 months ago

BioNxt Solutions obtient l'acceptation de son brevet auprès de l'Organisation eurasienne des brevets

Innovation Maladies Auto-immunes Solutions BioNxt Administration De Médicaments Brevet Eurasien
PRESS RELEASE

published on 05/05/2025 at 09:05, 7 months ago

BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
BioNxt Solutions Inc. announces acceptance of its first national level patent filing by Eurasian Patent Organization, covering sublingual drug delivery for neurodegenerative diseases

BioNxt Solutions Inc. Patent Filing Neurodegenerative Diseases Sublingual Delivery Eurasian Patent Organization
BRIEF

published on 05/02/2025 at 01:55, 7 months 3 days ago

BioNxt Solutions Delays 2024 Annual Financial Statement Filing

Management Cease Trade Order Healthcare Innovation Financial Statements Delay Annual Filings BioNxt Solutions
BRIEF

published on 05/02/2025 at 01:55, 7 months 3 days ago

BioNxt Solutions retarde le dépôt de ses états financiers annuels pour 2024

Dépôts Annuels Solutions BioNxt Retard Des États Financiers Innovation Dans Le Domaine Des Soins De Santé Ordonnance De Cessation D'opérations De La Direction
PRESS RELEASE

published on 05/02/2025 at 01:50, 7 months 3 days ago

BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements
BioNxt Solutions Inc. announces delay in filing annual financial statements for year ended December 31, 2024. Company working on completing filings by June 28, 2025, under management cease trade order

Financial Statements Management Cease Trade Order BioNxt Solutions Inc. Delay Regulatory Authorities
BRIEF

published on 04/23/2025 at 09:10, 7 months 12 days ago

BioNxt Solutions Advances in MS Treatment Study

Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study

Accesswire

Published on 12/06/2025 at 00:00, 27 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 57 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour 37 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 42 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 57 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 2 hours 11 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 14 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 28 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 6 hours ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 6 hours 11 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 1 hour 27 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 27 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 27 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 27 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 9 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE